Deva Holding AS | DEVA - Aset Lancar

Keuangan

TRY

TRY 12.93B

TRY 775.92M

Biaya Penjualan

TRY 991.13M

TRY 9.13B

Kewajiban Lancar

TRY 6.43B

TRY 5.3B

Dividen - Hasil

0.18

TRY 820.88M

TRY 882.9M

Eps Laba Per Saham

TRY 2.92

Modal Dan Cadangan

TRY 5.79B

Laba Kotor Pada Penjualan

TRY 1.32B

Beban Bunga Utang

TRY 272.53M

TRY 559.97M

Kapitalisasi Pasar

TRY 14.26B

Batas Pemasukan

TRY 583.98M

Biaya Operasional

TRY 1.35B

Laba Operasional

TRY 964.87M

Modal Saham Biasa

TRY 200.02M

Pe Harga Untuk Laba

6.55

Pendapatan Penjualan

TRY 2.32B

Beban Penjualan Dan Administrasi

TRY 462.26M

Kreditur Perdagangan

TRY 809.81M

Debitur Perdagangan

TRY 3.03B

	Aset Lancar	Perubahan		Tanggal
Akebia Therapeutics	USD 243.48M		9.47M	2026-03
Alaunos Therapeutics	USD 1.99M		697K	2025-12
Avita Medical	AUD 35.49M		760K	2025-12
Deva Holding AS	TRY 9.13B		1.61B	2023-09
Dianthus Therapeutics	USD 1.12B		710.47M	2026-03
Ionis Pharmaceuticals	USD 2.94B		52M	2026-03
IQVIA Holdings	USD 6.22B		29M	2026-03
Moderna	USD 5.77B		774M	2026-03
Organon & Co	USD 4.93B		580M	2026-03
Revvity	USD 2.13B		111.43M	2026-03
Tectonic Therapeutic	USD 239.89M		17.47M	2026-03
Viatris	USD 10.92B		1.13B	2026-03
Xeris Pharmaceuticals	USD 251.68M		11.37M	2026-03